Literature DB >> 11087258

Mechanisms of I(Ks) suppression in LQT1 mutants.

L Bianchi1, S G Priori, C Napolitano, K A Surewicz, A T Dennis, M Memmi, P J Schwartz, A M Brown.   

Abstract

Mutations in the cardiac potassium ion channel gene KCNQ1 (voltage-gated K(+) channel subtype KvLQT1) cause LQT1, the most common type of hereditary long Q-T syndrome. KvLQT1 mutations prolong Q-T by reducing the repolarizing cardiac current [slow delayed rectifier K(+) current (I(Ks) )], but, for reasons that are not well understood, the clinical phenotypes may vary considerably even for carriers of the same mutation, perhaps explaining the mode of inheritance. At present, only currents expressed by LQT1 mutants have been studied, and it is unknown whether abnormal subunits are transported to the cell surface. Here, we have examined for the first time trafficking of KvLQT1 mutations and correlated the results with the I(Ks) currents that were expressed. Two missense mutations, S225L and A300T, produced abnormal currents, and two others, Y281C and Y315C, produced no currents. However, all four KvLQT1 mutations were detected at the cell surface. S225L, Y281C, and Y315C produced dominant negative effects on wild-type I(Ks) current, whereas the mutant with the mildest dysfunction, A300T, did not. We examined trafficking of a severe insertion deletion mutant Delta544 and detected this protein at the cell surface as well. We compared the cellular and clinical phenotypes and found a poor correlation for the severely dysfunctional mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087258     DOI: 10.1152/ajpheart.2000.279.6.H3003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

1.  Structural models for the KCNQ1 voltage-gated potassium channel.

Authors:  Jarrod A Smith; Carlos G Vanoye; Alfred L George; Jens Meiler; Charles R Sanders
Journal:  Biochemistry       Date:  2007-11-14       Impact factor: 3.162

2.  High-Throughput Functional Evaluation of KCNQ1 Decrypts Variants of Unknown Significance.

Authors:  Carlos G Vanoye; Reshma R Desai; Katarina L Fabre; Shannon L Gallagher; Franck Potet; Jean-Marc DeKeyser; Daniela Macaya; Jens Meiler; Charles R Sanders; Alfred L George
Journal:  Circ Genom Precis Med       Date:  2018-11

Review 3.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

Review 4.  Cardiac Delayed Rectifier Potassium Channels in Health and Disease.

Authors:  Lei Chen; Kevin J Sampson; Robert S Kass
Journal:  Card Electrophysiol Clin       Date:  2016-04-01

5.  Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity.

Authors:  Sam Chai; Xiaoping Wan; Angelina Ramirez-Navarro; Paul J Tesar; Elizabeth S Kaufman; Eckhard Ficker; Alfred L George; Isabelle Deschênes
Journal:  J Clin Invest       Date:  2018-02-12       Impact factor: 14.808

6.  PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors.

Authors:  Alessandra Matavel; Coeli M B Lopes
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

7.  Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes.

Authors:  Sergey Missan; Paul Linsdell; Terence F McDonald
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

8.  Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Authors:  Arthur J Moss; Wataru Shimizu; Arthur A M Wilde; Jeffrey A Towbin; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Michael J Ackerman; Elizabeth S Kaufman; Nynke Hofman; Rahul Seth; Shiro Kamakura; Yoshihiro Miyamoto; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

9.  Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activation.

Authors:  Georg Kuenze; Carlos G Vanoye; Reshma R Desai; Sneha Adusumilli; Kathryn R Brewer; Hope Woods; Eli F McDonald; Charles R Sanders; Alfred L George; Jens Meiler
Journal:  Elife       Date:  2020-10-23       Impact factor: 8.140

10.  QT interval prolongation associated with sibutramine treatment.

Authors:  Mira Harrison-Woolrych; David W J Clark; Geraldine R Hill; Mark I Rees; Jonathan R Skinner
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.